Anesthesia for Maternal–Fetal Interventions
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Clinical Policy: Fetal Surgery in Utero for Prenatally Diagnosed
Clinical Policy: Fetal Surgery in Utero for Prenatally Diagnosed Malformations Reference Number: CP.MP.129 Effective Date: 01/18 Coding Implications Last Review Date: 09/18 Revision Log Description This policy describes the medical necessity requirements for performing fetal surgery. This becomes an option when it is predicted that the fetus will not live long enough to survive delivery or after birth. Therefore, surgical intervention during pregnancy on the fetus is meant to correct problems that would be too advanced to correct after birth. Policy/Criteria I. It is the policy of Pennsylvania Health and Wellness® (PHW) that in-utero fetal surgery (IUFS) is medically necessary for any of the following: A. Sacrococcygeal teratoma (SCT) associated with fetal hydrops related to high output heart failure : SCT resecton: B. Lower urinary tract obstruction without multiple fetal abnormalities or chromosomal abnormalities: urinary decompression via vesico-amniotic shunting C. Ccongenital pulmonary airway malformation (CPAM) and extralobar bronchopulmonary sequestration with hydrops (hydrops fetalis): resection of malformed pulmonary tissue, or placement of a thoraco-amniotic shunt; D. Twin-twin transfusion syndrome (TTTS): treatment approach is dependent on Quintero stage, maternal signs and symptoms, gestational age and the availability of requisite technical expertise and include either: 1. Amnioreduction; or 2. Fetoscopic laser ablation, with or without amnioreduction when member is between 16 and 26 weeks gestation; E. Twin-reversed-arterial-perfusion (TRAP): ablation of anastomotic vessels of the acardiac twin (laser, radiofrequency ablation); F. Myelomeningocele repair when all of the following criteria are met: 1. Singleton pregnancy; 2. Upper boundary of myelomeningocele located between T1 and S1; 3. -
Guide to Learning in Maternal-Fetal Medicine
GUIDE TO LEARNING IN MATERNAL-FETAL MEDICINE First in Women’s Health The Division of Maternal-Fetal Medicine of The American Board of Obstetrics and Gynecology, Inc. 2915 Vine Street Dallas, TX 75204 Direct questions to: ABOG Fellowship Department 214.871.1619 (Main Line) 214.721.7526 (Fellowship Line) 214.871.1943 (Fax) [email protected] www.abog.org Revised 4/2018 1 TABLE OF CONTENTS I. INTRODUCTION ........................................................................................................................ 3 II. DEFINITION OF A MATERNAL-FETAL MEDICINE SUBSPECIALIST .................................... 3 III. OBJECTIVES ............................................................................................................................ 3 IV. GENERAL CONSIDERATIONS ................................................................................................ 3 V. ENDOCRINOLOGY OF PREGNANCY ..................................................................................... 4 VI. PHYSIOLOGY ........................................................................................................................... 6 VII. BIOCHEMISTRY ........................................................................................................................ 9 VIII. PHARMACOLOGY .................................................................................................................... 9 IX. PATHOLOGY ......................................................................................................................... -
A Comprehensive Guide Ram Roth Elizabeth A.M. Frost Clifford Gevirtz
The Role of Anesthesiology in Global Health A Comprehensive Guide Ram Roth Elizabeth A.M. Frost Cli ord Gevirtz Editors Carrie L.H. Atcheson Associate Editor 123 The Role of Anesthesiology in Global Health Ram Roth • Elizabeth A.M. Frost Clifford Gevirtz Editors Carrie L.H. Atcheson Associate Editor The Role of Anesthesiology in Global Health A Comprehensive Guide Editors Ram Roth Elizabeth A.M. Frost Department of Anesthesiology Department of Anesthesiology Icahn School of Medicine at Mount Sinai Icahn School of Medicine at Mount Sinai New York , NY , USA New York , NY , USA Clifford Gevirtz Department of Anesthesiology LSU Health Sciences Center New Orleans , LA , USA Associate Editor Carrie L.H. Atcheson Oregon Anesthesiology Group Department of Anesthesiology Adventist Medical Center Portland , OR , USA ISBN 978-3-319-09422-9 ISBN 978-3-319-09423-6 (eBook) DOI 10.1007/978-3-319-09423-6 Springer Cham Heidelberg New York Dordrecht London Library of Congress Control Number: 2014956567 © Springer International Publishing Switzerland 2015 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifi cally the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfi lms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. Exempted from this legal reservation are brief excerpts in connection with reviews or scholarly analysis or material supplied specifi cally for the purpose of being entered and executed on a computer system, for exclusive use by the purchaser of the work. -
Orientation for New Clinicians
PROFESSIONAL AFFAIRS ORIENTATION FOR NEW CLINICIANS TABLE OF CONTENTS SCORE: CLINICAL ORIENTATION ........................................................................................... 4 I. SCHEDULE ........................................................................................................................ 5 A. QGenda ......................................................................................................................... 5 B. Weekly Schedule .......................................................................................................... 5 C. OR Daily Schedule ....................................................................................................... 5 D. Anesthesia Daily Call Team ......................................................................................... 6 II. ELECTRONIC MEDICAL RECORD ............................................................................... 6 A. BIDMC Portal: ............................................................................................................. 6 B. Anesthesia Intranet ....................................................................................................... 6 C. Perioperative Information Management System (PIMS) ............................................. 7 D. Talis: ............................................................................................................................. 7 E. Online Medical Record (OMR): .................................................................................. -
(EXIT), a Resuscitation Option for Intra-Thoracic Foetal Pathologies
Original article SWISS MED WKLY 2007;137:279–285 · www.smw.ch 279 Peer reviewed article Ex utero intrapartum treatment (EXIT), a resuscitation option for intra-thoracic foetal pathologies Christian Kerna, Michel Ange, Moralesb, Barbara Peiryc, Riccardo E. Pfisterc a Anaesthesia, University Hospital Geneva, Switzerland b Gynaecology and Obstetrics, University Hospital Geneva, Switzerland c Paediatrics, University Hospital Geneva, Switzerland Summary The ex utero intrapartum treatment (EXIT) requires a caesarean section that specifically differs procedure is designed to guarantee sufficient oxy- from the traditional caesarean section during genation for a foetus at risk of airway obstruction. which uterine tone is maintained to minimize ma- This is achieved by improving lung ventilation, ternal bleeding. To guarantee foetal oxygenation usually by establishing an airway during caesarean during the EXIT procedure, profound uterine delivery whilst preserving the foetal-placental cir- relaxation is desired. To gain time with optimal culation temporarily. Indications for the EXIT placental oxygenation in order to safely perform an procedure have extended from its original use in airway intervention in a baby at risk of hypoxia may reversing iatrogenic tracheal obstruction in con- require deep inhalation anaesthesia and/or to- genital diaphragmatic hernia to naturally occur- colytic agents. We review the EXIT procedure and ring upper airway obstructions. We report our present a case series from the University Hospital experience with a new and rarely mentioned indi- of Geneva that contrasts with the common indica- cation for the EXIT procedure, intra-thoracic tion for the EXIT procedure usually based on volume expansions. The elaboration of lowest risk upper airway obstruction by its exclusive indica- scenarios through balancing risks with alternative tion for intra-thoracic malformations/diseases. -
Curriculum Vitae Michael A. Frölich, MD Anesthesiology And
Curriculum Vitae Michael A. Frölich, MD Anesthesiology and Perioperative Medicine University of Alabama at Birmingham School of Medicine Office Address: 619 19th Street South. Birmingham, AL 35249-6810 Office Telephone: 001 (205) 975 – 0145 E-mail: [email protected] | [email protected] Citizenship: German | American Languages: German | English | Italian | Portuguese 1 Academic Appointments (reverse chronological order) University of Alabama at Birmingham Professor of Anesthesiology with Tenure 2012 - current Associate Professor of Anesthesiology with Tenure 2004 -2012 University of Florida Associate Professor of Anesthesiology with Tenure 2004 Assistant Professor of Anesthesiology 1998 -2004 Ludwig Maximilians Universität, München Facharzt für Anästhesie und Intensivmedizin 1996 -1998 Medical Training (reverse chronological order) Harvard University, Boston Fellowship in Obstetric Anesthesia 1995 -1996 Emory University, Atlanta Residency in Anesthesiology 1992 -1995 Internship in Medicine and Pediatrics (Transitional Year) 1991 -1992 Ludwig Maximilians Universität, Zentralklinikum Augsburg Arzt im Praktikum, Septische Intensivstation 1988 -1991 Universität Wien, Vienna, Austria Studium der Medizin 1982 -1988 Advanced Degrees University of Alabama at Birmingham M.S., Masters in Science of Biostatistics 2008 – 2012 University of Florida M.S., Masters in Science of Clinical Investigation (NIH K-30) 2001 – 2004 2 University Appointments University of Alabama System Faculty Representative to the Board of Trustees 2013 - 2014 University of -
Obstetric Anesthesiology: Practice Guidelines and You How to Avoid Surprises and Improve Outcomes by Mark Zakowski, M.D
Obstetric Anesthesiology: Practice Guidelines and You How to Avoid Surprises and Improve Outcomes By Mark Zakowski, M.D. s the speed of change seems to be increas- ing exponentially, we are often faced Awith information overload. One area that we cannot become lax about is the ever- increasing Practice Guidelines and Committee Opinions that affect the multidisciplinary area of obstetric anesthesiology. This article will review what national societies have urged upon their members, discussing new topics, as a continuation of a prior CME article in the Bulletin.1 The American College of Obstetricians and Gynecologists (ACOG) has released other documents that are very informative and pertinent to obstetric anesthesiol- ogy practice. This article will also review documents by the American Society of Anesthesiologists (ASA). Both societies have important guidelines that affect your daily practice. This review is intended to help you understand changes in clinical practice and to improve patient outcomes. Anesthesia When the Parturient Is on Antidepressants In February 2010, ACOG released a committee opinion stating that depression is very common before, during and after pregnancy. Indeed, one in seven pre- and postpartum women is treated for depression. Practitioners should be alert to signs of depression.2 Some women may be reluctant to mention a histo- ry of depression/mood disorder, especially in the presence of friends or family. Be sure to check the prenatal records or ask about this on the preanesthesia assessment. Moreover, antidepressant -
Hemodynamic Stability During Labor and Delivery with Continuous Epidural Infusion
ORIGINAL CONTRIBUTION Hemodynamic Stability During Labor and Delivery With Continuous Epidural Infusion Mark A. Gerhardt, MD, PhD Vit B. Gunka, MD Robert J. Miller, DO Context: Epidural anesthesia for labor pain is frequently com- Conclusions: Continuous epidural infusion of 0.2% ropiva- plicated by maternal hypotension. caine hydrochloride without bolus administration reduces the incidence of hypotension by 67% and is safer than tradi- Objective: To test whether continuous epidural infusion (CEI) tional bolus dosing for routine labor. This method requires fur- of local anesthetic, without bolus administration, lowers the ther study in high-risk patients, including those with incidence of hypotension in parturient patients. preeclampsia and cardiovascular disease. Methods: In a single-blind clinical study, subjects were ran- J Am Osteopath Assoc. 2006;106:692-698 domly assigned to CEI-only (10 mL/h of 0.2% ropivacaine hydrochloride without bolus) or control (10 mL of 0.2% ropi- ost parturient patients elect to receive epidural anes- vacaine hydrochloride per hour with 10-mL bolus) epidural Mthesia to ease the physical demands and discomfort of dosing groups. The incidence of hypotension (20% decrease childbirth.1 However, epidural anesthesia is frequently asso- in systolic blood pressure or mean arterial pressure (MAP), sys- ciated with hypotension,2,3 requiring intervention with fluid tolic blood pressure lower than 100 mm Hg, or MAP lower and/or vasopressors. Furthermore, the fetus may be com- than 65 mm Hg) was recorded for 2 hours after dosing. Sta- promised because uterine blood flow depends on maternal tistical analysis included a 2ϫ2 2 analysis, the Fisher exact test, perfusion.4 Fetal distress can develop rapidly. -
A Virtual Event May 13-16 Program Guide
SOAP 2021 Annual Meeting Building Moving Bridges Forward A Virtual Event May 13-16 Program Guide Jointly provided by the American Society of Anesthesiologists and the Society for Obstetric Anesthesia and Perinatology. #SOAPAM2021 // SOAP 2021 Annual Meeting- Building Bridges and Moving Forward Jump to Table of Contents The Society for Obstetric Anesthesia and Perinatology would like to thank the following Supporters of the SOAP 53rd Annual Meeting. PLATINUM SPONSOR BRONZE SPONSORS MEDIA PARTNER Page - 2 // // SOAP 2021 Annual Meeting- Building Bridges and Moving Forward Jump to Table of Contents SOAP 53rd Virtual Annual Meeting Building Bridges & Moving Forward Welcome Letter ...............................................................................................................4 Planning Committees ......................................................................................................6 Program Faculty ................................................................................................................7 Program Information & Policies .......................................................................................16 Session Descriptions ........................................................................................................19 Program Schedule Thursday ............................................................................................22 Program Schedule Friday .................................................................................................24 Program Schedule -
From 'OOPS to EXIT': a Review of the Origins and Progression of Ex Utero
a & hesi C st lin e ic n a A l f R o e l s Journal of Anesthesia & Clinical e a a n r r c u h o Nnamani, J Anesth Clin Res 2015, 6:7 J ISSN: 2155-6148 Research DOI: 10.4172/2155-6148.1000540 Review Article Open Access From ‘OOPS to EXIT’: A Review of the Origins and Progression of Ex Utero Intrapartum Treatment Nwamaka Nnamani* UTSW Anesthesiology, 5323 Harry Hines Blvd, Dallas, Texas 75390-9068, USA *Corresponding author: Nwamaka Nnamani, Assistant Instructor, UTSW Anesthesiology, 5323 Harry Hines Blvd, Dallas, Texas 75390-9068, USA, Tel: 773-749-2220; E-mail: [email protected] Received date: Feb 27, 2015, Accepted date: July 08, 2015, Published date: July 13, 2015 Copyright: © 2015 Nnamani N. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Advancement in the safety of obstetric anesthesiology has largely been due to better pharmacotherapy, monitoring devices and airway adjuncts. Similarly, the rate of fetal mortality has declined in the last two decades particularly due to improved neonatal intensive care and the wide-spread use of surfactant for premature births. The field of perinatology has long recognized that certain high-risk fetal anomalies, which previously carried significant mortality rates may now be amenable to the Ex Utero Intrapartum Treatment (EXIT). This review discusses the history of EXIT and focuses on the role of the anesthesiologist during this procedure; with emphasis that the successful outcome of many EXIT procedures is a testament to the advancements in obstetric anesthesiology, our understanding of maternal and fetal physiology, safer anesthetic agents, and improved overall safety of general anesthesia in parturients. -
Techniques of Fetal Intervention What Is Fetal Intervention?
Techniques of Fetal Intervention What is fetal intervention? Fetal intervention is reaching inside the uterus to help a fetus who has a problem. Our ability to detect fetal problems has advanced so rapidly over the last few decades. While many diseases can now be accurately diagnosed before birth by genetic and imaging techniques, only a few require intervention before birth. These are generally simple anatomic problems that cause ongoing damage to the developing fetus and can be corrected using the techniques described below. All fetal intervention is really maternal-fetal intervention, and the most important consideration in all fetal intervention is the safety of the mother: her current health and her furture reproductive potential. The intervention is designed to benefit the fetus who has a problem, but the mother is an innocent bystander who assumes some risk for the sake of her unborn fetus. In weighing the risks versus the benefits of an intervention, the most important consideration is the mother, her health, her family, and her ability in the future to have other children. What are the techniques of fetal intervention? There are three general approaches to fetal intervention, all of which have been developed in the last few decades. The most definitive and most invasive is open fetal surgery. Open Fetal Surgery Open Fetal Surgery Michael Harrison, MD In open fetal surgery, the mother is anesthetized, an incision is made in the lower abdomen to expose the uterus, the uterus is opened using a special stapling device to prevent bleeding, the surgical repair of the fetus is completed, the uterus followed by the maternal abdominal wall are closed, and the mother awakened. -
Obstetric Anesthesia and Heart Disease
REVIEW ARTICLE Deborah J. Culley, M.D., Editor ABSTRACT Maternal morbidity and mortality as a result of cardiac disease is increasing in the United States. Safe management of pregnancy in women with heart disease requires appropriate anesthetic, cardiac, and obstetric care. The Obstetric Anesthesia and anesthesiologist should risk stratify pregnant patients based upon cardiac Downloaded from http://pubs.asahq.org/anesthesiology/article-pdf/doi/10.1097/ALN.0000000000003833/506787/aln.0000000000003833.pdf by Marie-Louise Meng on 07 June 2021 disease etiology and severity in order to determine the appropriate type of Heart Disease: Practical hospital and location within the hospital for delivery and anesthetic manage- ment. Increased intrapartum hemodynamic monitoring may be necessary and Clinical Considerations neuraxial analgesia and anesthesia is typically appropriate. The anesthesiolo- gist should anticipate obstetric and cardiac emergencies such as emergency Marie-Louise Meng, M.D., Katherine W. Arendt, M.D. cesarean delivery, postpartum hemorrhage, and peripartum arrhythmias. This ANESTHESIOLOGY 2021; 135:164–83 clinical review answers practical questions for the obstetric anesthesiologist and the nonsubspecialist anesthesiologist who regularly practices obstetric anesthesiology. aternal mortality is increasing in the United States, (ANESTHESIOLOGY 2021; 135:164–83) Mand cardiovascular disease is now the leading cause.1,2 According to the Centers for Disease Control and Prevention, cardiovascular disease is currently responsible management of cardiovascular disease preconception, in preg- for one-quarter of maternal deaths in the United States and nancy, and in the peripartum and postpartum periods.12–14 similar trends are occurring in other high-income coun- These guidelines recommend that a “pregnancy heart team” tries.2–4 These trends may be a result of an increasing average care for pregnant patients with complex cardiovascular disease.